Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.

about

Lessons from characterization and treatment of the autoinflammatory syndromes.Effects of HLA-DRB1 alleles on susceptibility and clinical manifestations in Japanese patients with adult onset Still's disease.Review: Genetics and the Classification of Arthritis in Adults and Children.

P2860

Q39025839-F6122F9D-57FF-44BE-94CC-6884DF93BC5A Q40045121-9A8D8163-4F1B-4AFD-8DA7-0BD027B8E7B9 Q47811289-B04FA7D0-9661-458E-AF63-396438B64470

P2860

Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.

Item

http://www.wikidata.org/entity/Q36435446

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.

@ast

Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.

@en

type

Item

label

Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.

@ast

Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.

@en

prefLabel

Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.

@ast

Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.

@en

P1476

Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.

@en

P2093

Peter A Nigrovic

http://www.w3.org/2001/XMLSchema#string

P2860

A proposed classification of the immunological diseases

Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?

Juvenile idiopathic arthritis and HLA class I and class II interactions and age-at-onset effects.

Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis.

Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions.

Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features.

A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)

The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis.

HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis.

TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice.

P304

15785-15786

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1521837113

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26677874

http://www.w3.org/2001/XMLSchema#string

P921

juvenile rheumatoid arthritis

P932

4703029

http://www.w3.org/2001/XMLSchema#string

Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.

about

P2860

P2860

Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932